Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule Are Induced by Ionizing Radiation on Lymphatic Endothelium

International Journal of Radiation Oncology Biology Physics

Volumn 97, Issue 2, 2017, Pages 389-400

  Rodriguez Ruiz, María E ^a,b   Garasa, Saray ^a   Rodriguez, Inmaculada ^a   Solorzano, Jose Luis ^b   Barbes, Benigno ^b   Yanguas, Alba ^a,c   Teijeira, Alvaro ^a   Etxeberria, Iñaki ^a   Aristu, José Javier ^b   Halin, Cornelia ^d   Melero, Ignacio ^a,b   Rouzaut, Ana ^a,c  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

^c UNIVERSITY OF NAVARRA   (Spain)

^d ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION; ELECTROCHEMICAL CELLS; ENDOTHELIAL CELLS; IONIZING RADIATION; LINEAR ACCELERATORS; MAMMALS; MOLECULES; RADIATION EFFECTS; RADIATION SHIELDING; RADIOTHERAPY; TUMORS;

CLINICAL SAMPLES; CONFLUENT MONOLAYERS; HUMAN T LYMPHOCYTES; INTEGRIN LIGANDS; INTERCELLULAR ADHESION MOLECULE-1; TIME DEPENDENT; TISSUE SPECIMENS; VASCULAR CELL ADHESION;

X RAYS;

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ARTICLE; CANCER GRAFT; CANCER RADIOTHERAPY; CANCER TISSUE; CAPILLARY ENDOTHELIAL CELL; CD8+ T LYMPHOCYTE; CELL ADHESION; COLLIMATOR; CONFOCAL MICROSCOPY; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IONIZING RADIATION; LEUKOCYTE; LINEAR ACCELERATOR; LYMPH VESSEL ENDOTHELIUM; LYMPHATIC ENDOTHELIAL CELL; LYMPHOCYTIC INFILTRATION; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; REAL TIME POLYMERASE CHAIN REACTION; TISSUE CULTURE; TUMOR BIOPSY; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL MOTION; DEVICES; DRUG EFFECTS; FLUOROIMMUNOASSAY; MAGNETIC AND ELECTROMAGNETIC EQUIPMENT; METABOLISM; NEOPLASMS; PHYSIOLOGY; RADIATION RESPONSE; RANDOMIZATION; T LYMPHOCYTE; TIME FACTOR; TUMOR CELL LINE;

ANIMALS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENDOTHELIUM, LYMPHATIC; FLOW CYTOMETRY; FLUOROIMMUNOASSAY; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MICE; MICE, INBRED C57BL; NEOPLASMS; PARTICLE ACCELERATORS; RADIATION DOSAGE; RANDOM ALLOCATION; T-LYMPHOCYTES; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 85009088975     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2016.10.043     Document Type: Article

References (40)

1. 1 Karaman, S., Detmar, M., Mechanisms of lymphatic metastasis. J Clin Invest 124 (2014), 922–928.
2. 2 Melero, I., Rouzaut, A., Motz, G.T., et al. T-cell and NK-cell infiltration into solid tumors: A key limiting factor for efficacious cancer immunotherapy. Cancer Discov 4 (2014), 522–526.
3. 3 Bautch, V.L., Caron, K.M., Blood and lymphatic vessel formation. Cold Spring Harb Perspect Biol, 7, 2015, a008268.
4. 4 Swartz, M.A., Immunomodulatory roles of lymphatic vessels in cancer progression. Cancer Immunol Res 2 (2014), 701–707.
5. 5 Siemann, D.W., Horsman, M.R., Modulation of the tumor vasculature and oxygenation to improve therapy. Pharmacol Ther 153 (2015), 107–124.
6. 6 Kim, J.H., Jenrow, K.A., Brown, S.L., Mechanisms of radiation-induced normal tissue toxicity and implications for future clinical trials. Radiat Oncol J 32 (2014), 103–115.
7. 7 Avraham, T., Yan, A., Zampell, J.C., et al. Radiation therapy causes loss of dermal lymphatic vessels and interferes with lymphatic function by TGF-beta1-mediated tissue fibrosis. Am J Physiol Cell Physiol 299 (2010), C589–C605.
8. 8 Sung, H.K., Morisada, T., Cho, C.H., et al. Intestinal and peri-tumoral lymphatic endothelial cells are resistant to radiation-induced apoptosis. Biochem Biophys Res Commun 345 (2006), 545–551.
9. 9 Jackowski, S., Janusch, M., Fiedler, E., et al. Radiogenic lymphangiogenesis in the skin. Am J Pathol 171 (2007), 338–348.
10. 10 Förster, R., Braun, A., Worbs, T., Lymph node homing of T cells and dendritic cells via afferent lymphatics. Trends Immunol 33 (2012), 271–280.
11. 11 Teijeira, A., Rouzaut, A., Melero, I., Initial afferent lymphatic vessels controlling outbound leukocyte traffic from skin to lymph nodes. Front Immunol, 4, 2013, 433.
12. 12 Barker, H.E., Paget, J.T., Khan, A.A., et al. The tumour microenvironment after radiotherapy: Mechanisms of resistance and recurrence. Nat Rev Cancer 15 (2015), 409–425.
13. 13 Melero, I., Grimaldi, A.M., Perez-Gracia, J.L., et al. Clinical development of immunostimulatory monoclonal antibodies and opportunities for combination. Clin Cancer Res 19 (2013), 997–1008.
14. 14 Pilones, K.A., Vanpouille-Box, C., Demaria, S., Combination of radiotherapy and immune checkpoint inhibitors. Semin Radiat Oncol 25 (2015), 28–33.
15. 15 Teijeira, A., Garasa, S., Peláez, R., et al. Lymphatic endothelium forms integrin-engaging 3D structures during DC transit across inflamed lymphatic vessels. J Invest Dermatol 133 (2013), 2276–2285.
16. 16 Rouzaut, A., Garasa, S., Teijeira, A., et al. Dendritic cells adhere to and transmigrate across lymphatic endothelium in response to IFN-α. Eur J Immunol 40 (2010), 3054–3063.
17. 17 Vigl, B., Aebischer, D., Nitschké, M., et al. Tissue inflammation modulates gene expression of lymphatic endothelial cells and dendritic cell migration in a stimulus-dependent manner. Blood 118 (2011), 205–215.
18. 18 Arbea, L., Martínez-Monge, R., Díaz-González, J.A., et al. Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: A validation phase II trial. Int J Radiat Oncol Biol Phys 83 (2012), 587–593.
19. 19 Moreno-Jiménez, M., Valero, J., López-Picazo, J.M., et al. Concomitant cisplatin, paclitaxel, and hyperfractionated radiotherapy in locally advanced head and neck cancer: Comparison of two different schedules. Am J Clin Oncol 33 (2010), 137–143.
20. 20 Irigoyen, M., Ansó, E., Salvo, E., et al. TGFbeta-induced protein mediates lymphatic endothelial cell adhesion to the extracellular matrix under low oxygen conditions. Cell Mol Life Sci 65 (2008), 2244–2255.
21. 21 Johnson, L.A., Clasper, S., Holt, A.P., et al. An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J Exp Med 203 (2006), 2763–2777.
22. 22 Kesler, C.T., Kuo, A.H., Wong, H.K., et al. Vascular endothelial growth factor-C enhances radiosensitivity of lymphatic endothelial cells. Angiogenesis 17 (2014), 419–427.
23. 23 Gaugler, M.H., Squiban, C., van der Meeren, A., et al. Late and persistent up-regulation of intercellular adhesion molecule-1 (ICAM-1) expression by ionizing radiation in human endothelial cells in vitro. Int J Radiat Biol 72 (1997), 201–209.
24. 24 Quarmby, S., Kumar, P., Kumar, S., Radiation-induced normal tissue injury: Role of adhesion molecules in leukocyte-endothelial cell interactions. Int J Cancer 82 (1999), 385–395.
25. 25 Burnette, B.C., Liang, H., Lee, Y., et al. The efficacy of radiotherapy relies upon induction of type I interferon-dependent innate and adaptive immunity. Cancer Res 71 (2011), 2488–2496.
26. 26 Rey, B., Hehlgans, S., Rödel, F., et al. Modulation of inflammation by low and high doses of ionizing radiation: Implications for benign and malign diseases. Cancer Lett 368 (2015), 230–237.
27. 27 Chen, J.C., Chang, Y.W., Hong, C.C., et al. The role of the VEGF-C/VEGFRs axis in tumor progression and therapy. Int J Mol Sci 14 (2012), 88–107.
28. 28 Yang, Y., Oliver, G., Development of the mammalian lymphatic vasculature. J Clin Invest 124 (2014), 888–897.
29. 29 Lund, A.W., Medler, T.R., Leachman, S.A., et al. Lymphatic vessels, inflammation, and immunity in skin cancer. Cancer Discov 6 (2016), 22–35.
30. 30 Demaria, S., Golden, E.B., Formenti, S.C., Role of local radiation therapy in cancer immunotherapy. JAMA Oncol 1 (2015), 1325–1332.
31. 31 Havaki, S., Kotsinas, A., Chronopoulos, E., et al. The role of oxidative DNA damage in radiation induced bystander effect. Cancer Lett 356 (2015), 43–51.
32. 32 Vanpouille-Box, C., Diamond, J.M., Pilones, K.A., et al. TGFβ is a master regulator of radiation therapy-induced antitumor immunity. Cancer Res 75 (2015), 2232–2242.
33. 33 Tu, E., Chia, P.Z., Chen, W., TGFβ in T cell biology and tumor immunity: Angel or devil?. Cytokine Growth Factor Rev 25 (2014), 423–435.
34. 34 Martín-Fontecha, A., Lanzavecchia, A., Sallusto, F., Dendritic cell migration to peripheral lymph nodes. Handb Exp Pharmacol, 2009, 31–49.
35. 35 Brown, M.N., Fintushel, S.R., Lee, M.H., et al. Chemoattractant receptors and lymphocyte egress from extralymphoid tissue: Changing requirements during the course of inflammation. J Immunol 185 (2010), 4873–4882.
36. 36 Vanpouille-Box, C., Pilones, K.A., Wennerberg, E., et al. In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment. Vaccine 33 (2015), 7415–7422.
37. 37 Cummings, R.J., Gerber, S.A., Judge, J.L., et al. Exposure to ionizing radiation induces the migration of cutaneous dendritic cells by a CCR7-dependent mechanism. J Immunol 189 (2012), 4247–4257.
38. 38 Melero, I., Berman, D.M., Aznar, M.A., et al. Evolving synergistic combinations of targeted immunotherapies to combat cancer. Nat Rev Cancer 15 (2015), 457–472.
39. 39 Obeid, M., Panaretakis, T., Tesniere, A., et al. Leveraging the immune system during chemotherapy: Moving calreticulin to the cell surface converts apoptotic death from “silent” to immunogenic. Cancer Res 67 (2007), 7941–7944.
40. 40 Abastado, J.P., The next challenge in cancer immunotherapy: Controlling T-cell traffic to the tumor. Cancer Res 72 (2012), 2159–2161.